A Randomized Controlled Trial of Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery

Survey of Anesthesiology ◽

10.1097/00132586-198708000-00034 ◽

1987 ◽

Vol XXXI (4) ◽

pp. 225

Author(s):

A. G. G. TURPIE ◽

M. N. LEVINE ◽

J. HIRSH ◽

C. J. CARTER ◽

R. M. JAY ◽

...

Keyword(s):

Molecular Weight ◽

Randomized Controlled Trial ◽

Deep Vein Thrombosis ◽

Low Molecular Weight Heparin ◽

Controlled Trial ◽

Hip Surgery ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Randomized Controlled ◽

Download Full-text

A randomized controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep vein thrombosis in patients undergoing elective hip surgery

Journal of Vascular Surgery ◽

10.1016/0741-5214(87)90025-5 ◽

1987 ◽

Vol 6 (4) ◽

pp. 427-428

Author(s):

Anthony D. Whittemore

Keyword(s):

Molecular Weight ◽

Randomized Controlled Trial ◽

Deep Vein Thrombosis ◽

Low Molecular Weight Heparin ◽

Controlled Trial ◽

Hip Surgery ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Randomized Controlled ◽

Download Full-text

A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery

New England Journal of Medicine ◽

10.1056/nejm198610093151503 ◽

1986 ◽

Vol 315 (15) ◽

pp. 925-929 ◽

Author(s):

Alexander G.G. Turpie ◽

Mark N. Levine ◽

Jack Hirsh ◽

Cedric J. Carter ◽

Richard M. Jay ◽

...

Keyword(s):

Molecular Weight ◽

Randomized Controlled Trial ◽

Deep Vein Thrombosis ◽

Low Molecular Weight Heparin ◽

Controlled Trial ◽

Hip Surgery ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Randomized Controlled ◽

Download Full-text

Prophylaxis for deep vein thrombosis with aspirin or low molecular weight dextran in Korean patients undergoing total hip replacement;a randomized controlled trial

International Orthopaedics ◽

10.1007/s002640050199 ◽

1998 ◽

Vol 22 (1) ◽

pp. 6-10 ◽

Author(s):

Y. H. Kim ◽

I. Y. Choi ◽

M. R. Park ◽

T. S. Park ◽

J. L. Cho

Keyword(s):

Molecular Weight ◽

Randomized Controlled Trial ◽

Deep Vein Thrombosis ◽

Total Hip Replacement ◽

Hip Replacement ◽

Controlled Trial ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Randomized Controlled ◽

Download Full-text

Evidence-Based Evaluation of Preoperative vs Postoperative Use of Low-Molecular-Weight Heparin in Preventing Deep Vein Thrombosis in Elective Hip Surgery

Archives of Internal Medicine ◽

10.1001/archinte.159.14.1622 ◽

1999 ◽

Vol 159 (14) ◽

pp. 1622-1623

Author(s):

A. Ghosh

Keyword(s):

Molecular Weight ◽

Deep Vein Thrombosis ◽

Low Molecular Weight Heparin ◽

Hip Surgery ◽

Low Molecular Weight ◽

Evidence Based ◽

Vein Thrombosis ◽

Download Full-text

Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery

British Journal of Haematology ◽

10.1046/j.1365-2141.1999.01153.x ◽

1999 ◽

Vol 104 (2) ◽

pp. 230-240 ◽

Author(s):

Lucienne Bara ◽

André Planes ◽

Meyer-Michel Samama

Keyword(s):

Molecular Weight ◽

Deep Vein Thrombosis ◽

Plasma Levels ◽

Low Molecular Weight Heparin ◽

Hip Surgery ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Deep Vein ◽

Download Full-text

Randomized Trial of a Low-Molecular-Weight Heparin (Kabi 2165) versus Adjusted-Dose Subcutaneous Standard Heparin in the Prophylaxis of Deep-Vein Thrombosis after Elective Hip Surgery

Pathophysiology of Haemostasis and Thrombosis ◽

10.1159/000215882 ◽

1989 ◽

Vol 19 (1) ◽

pp. 5-12 ◽

Author(s):

M. Dechavanne ◽

D. Ville ◽

M. Berruyer ◽

F. Trepo ◽

F. Dalery ◽

...

Keyword(s):

Molecular Weight ◽

Deep Vein Thrombosis ◽

Randomized Trial ◽

Low Molecular Weight Heparin ◽

Hip Surgery ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Deep Vein ◽

Download Full-text

Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin

Journal of Vascular Surgery ◽

10.1016/0741-5214(93)90354-o ◽

1993 ◽

Vol 18 (5) ◽

pp. 899-900

Author(s):

Jean-Baptiste Ricco

Keyword(s):

Molecular Weight ◽

Deep Vein Thrombosis ◽

Unfractionated Heparin ◽

Randomized Trial ◽

Low Molecular Weight Heparin ◽

Hip Surgery ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Download Full-text

A randomised controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep-vein thrombosis in patients undergoing vascular surgery

European Journal of Vascular Surgery ◽

10.1016/s0950-821x(05)80369-x ◽

1993 ◽

Vol 7 (5) ◽

pp. 554-560 ◽

Author(s):

J.C. Farkas ◽

C. Chapuis ◽

S. Combe ◽

M. Silsiguen ◽

J. Marzelle ◽

...

Keyword(s):

Molecular Weight ◽

Deep Vein Thrombosis ◽

Randomised Controlled Trial ◽

Vascular Surgery ◽

Low Molecular Weight Heparin ◽

Controlled Trial ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Randomised Controlled ◽

Download Full-text

Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients

Thrombosis Research ◽

10.1016/0049-3848(90)90422-9 ◽

1990 ◽

Vol 59 (3) ◽

pp. 639-650 ◽

Author(s):

J. Harenberg ◽

B. Kallenbach ◽

U. Martin ◽

C.E. Dempfle ◽

R. Zimmermann ◽

...

Keyword(s):

Molecular Weight ◽

Deep Vein Thrombosis ◽

Low Molecular Weight Heparin ◽

Randomized Controlled Study ◽

Controlled Study ◽

Low Molecular Weight ◽

Medical Patients ◽

Vein Thrombosis ◽

Randomized Controlled ◽

Download Full-text

Faculty Opinions recommendation of Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1124847.581938 ◽

2008 ◽

Author(s):

Mark Hamilton ◽

Marcus Peck

Keyword(s):

Molecular Weight ◽

Deep Vein Thrombosis ◽

Renal Insufficiency ◽

Critically Ill ◽

Critically Ill Patients ◽

Low Molecular Weight Heparin ◽

Low Molecular Weight ◽

Vein Thrombosis ◽

Severe Renal Insufficiency ◽

Download Full-text